Bone disease associated with antiepileptic drugs

Alison M. Pack, MD
Neurological Institute, Columbia Presbyterian Medical Center, New York, NY

Barry Gidal, PharmD
University of Wisconsin, Madison, WI

Blanca Vazquez, MD
New York University School of Medicine, New York, NY

Correspondence: Alison M. Pack, MD, The Neurological Institute, Columbia Presbyterian Medical Center, 710 W. 168th Street, New York, NY 10032; e-mail: [email protected]

Dr. Pack receives grants/research support from GlaxoSmithKline, Novartis, UCB Pharma, and Cyberonics, and has received honoraria from GlaxoSmithKline, Novartis, Ortho-McNeil, and Elan.

Dr. Gidal receives grants/research support from GlaxoSmithKline and UCB Pharma; is a consultant for GlaxoSmithKline, UCB Pharma, and Ivax; and has received honoraria from GlaxoSmithKline, UCB Pharma, and Novartis.

Dr. Vazquez receives grants/research support from, is a consultant for, and has received honoraria from Abbott, UCB Pharma, Elan, Novartis, Schwarz Pharma, GlaxoSmithKline, Ortho-McNeil, and Pfizer.

Alison M. Pack, MD
Neurological Institute, Columbia Presbyterian Medical Center, New York, NY

Barry Gidal, PharmD
University of Wisconsin, Madison, WI

Blanca Vazquez, MD
New York University School of Medicine, New York, NY

Correspondence: Alison M. Pack, MD, The Neurological Institute, Columbia Presbyterian Medical Center, 710 W. 168th Street, New York, NY 10032; e-mail: [email protected]

Dr. Pack receives grants/research support from GlaxoSmithKline, Novartis, UCB Pharma, and Cyberonics, and has received honoraria from GlaxoSmithKline, Novartis, Ortho-McNeil, and Elan.

Dr. Gidal receives grants/research support from GlaxoSmithKline and UCB Pharma; is a consultant for GlaxoSmithKline, UCB Pharma, and Ivax; and has received honoraria from GlaxoSmithKline, UCB Pharma, and Novartis.

Dr. Vazquez receives grants/research support from, is a consultant for, and has received honoraria from Abbott, UCB Pharma, Elan, Novartis, Schwarz Pharma, GlaxoSmithKline, Ortho-McNeil, and Pfizer.

Alison M. Pack, MD
Neurological Institute, Columbia Presbyterian Medical Center, New York, NY

Barry Gidal, PharmD
University of Wisconsin, Madison, WI

Blanca Vazquez, MD
New York University School of Medicine, New York, NY

Correspondence: Alison M. Pack, MD, The Neurological Institute, Columbia Presbyterian Medical Center, 710 W. 168th Street, New York, NY 10032; e-mail: [email protected]

Dr. Pack receives grants/research support from GlaxoSmithKline, Novartis, UCB Pharma, and Cyberonics, and has received honoraria from GlaxoSmithKline, Novartis, Ortho-McNeil, and Elan.

Dr. Gidal receives grants/research support from GlaxoSmithKline and UCB Pharma; is a consultant for GlaxoSmithKline, UCB Pharma, and Ivax; and has received honoraria from GlaxoSmithKline, UCB Pharma, and Novartis.

Dr. Vazquez receives grants/research support from, is a consultant for, and has received honoraria from Abbott, UCB Pharma, Elan, Novartis, Schwarz Pharma, GlaxoSmithKline, Ortho-McNeil, and Pfizer.